Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

BACKGROUND: Early screening and intervention therapies are crucial to improve the prognosis of hepatocellular carcinoma (HCC) patients with bone metastasis. We aimed to identify serum lncRNA as a prediction biomarker in HCC bone metastasis. METHODS: The expression levels of lnc34a in serum samples f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Niu, Hao, Yang, Ping, Ma, Jie, Yuan, Bao-Ying, Zeng, Zhao-Chong, Xiang, Zuo-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885499/
https://www.ncbi.nlm.nih.gov/pubmed/33588789
http://dx.doi.org/10.1186/s12885-021-07808-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885499/
https://www.ncbi.nlm.nih.gov/pubmed/33588789
http://dx.doi.org/10.1186/s12885-021-07808-6

Ejemplares similares